Albunorm 20% is a pharmaceutical product from Octapharma which is a solution of human albumin for infusion. It contains 200 g/l of total protein, of which at least 96% is albumin, and is used to restore and maintain circulating blood volume in patients who have a deficiency.
The drug is prescribed in cases where blood volume replacement is required and the use of colloidal solutions such as albumin is appropriate. The product can be administered intravenously either undiluted or after dilution in an isotonic solution such as 5% glucose solution or 0.9% sodium chloride solution.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care.
Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.